DIIDROCODEINA IN ITALIA FUNDAMENTALS EXPLAINED

Hepatic Impairment Just after oral administration of just one 4 mg dose (2 mg hydromorphone rapid-launch tablets), indicate publicity to hydromorphone (Cmax and AUC∞) is elevated four-fold in patients with reasonable (Kid-Pugh Group B) hepatic impairment in comparison with subjects with standard hepatic purpose. Due to elevated exposure of hydrom